Post Marketing Rate of Seizures During Transcranial Magnetic Stimulation (TMS) Treatment with NeuroStar Advanced Therapy Is Lower Than Previously Estimated

• Bridget A. McGugan,
• Karen L. Heart,
• David G. Brock,
• Philip G. Janicak

Affiliations

Bridget A. McGugan

Bristol-Myers Squibb

Karen L. Heart

Neuronetics, Inc

David G. Brock

Bristol-Myers Squibb; Neuronetics, Inc; Northwestern University, Feinberg School of Medicine, Department of Psychiatry & Behavioral Sciences

Philip G. Janicak

Northwestern University, Feinberg School of Medicine, Department of Psychiatry & Behavioral Sciences